Cardiff Oncology, Inc. (CRDF)

3.15 -0.03 (-0.94%) USD  |  NASDAQ  |  Dec 26, 10:53
More

Cardiff Oncology Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for CRDF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
Agenus, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade